Erythropoietin receptor on cDC1s dictates immune tolerance
Year: 2025
Type: article
Source: Nature
Authors: Xiangyue Zhang, Christopher S. McGinnis, Guotao Yu, Sijie Chen, Pingping Zheng, Christian M. Schürch, Kamir J. Hiam-Galvez, Nathan E. Reticker-Flynn, Wenhui Guo, Winnie Yao, Jingtao Qiu, Alexander Muselman, Ian L. Linde, John W. Hickey, Hao Yan, Victoria M. Tran, Wenli Qiu, Delphine Brichart-Vernos, Toshihito Hirai, Bo Yu, Xiuli An, Yanling Xiao, Helena Paidassi, Tiffany C. Scharschmidt, Michael Angelo, Dean Sheppard, Hongbo Chi, Ansuman T. Satpathy, Sing Sing Way, Bernard Malissen, Samuel Strober, Edgar G. Engleman
Institutions: Stanford Medicine, Stanford University, Parker Institute for Cancer Immunotherapy, Universitätsklinikum Tübingen, University of Tübingen, Duke University, University of California, San Francisco, Lyon 1 Université, École Normale Supérieure de Lyon, Centre National de la Recherche Scientifique, Inserm, Université de Lyon, Centre International de Recherche en Infectiologie, New York Blood Center, Leiden University Medical Center, St. Jude Children's Research Hospital, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Aix-Marseille Université, Centre d’Immunologie de Marseille-Luminy, Stanford Cancer Institute
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Awards: Stanford Diabetes Research Center, Integrative Microbiology Program, Pancreatic Cancer Development: Genetic and Immune Regulation, Targeting Lymph Node Dependent Immune Tolerance in Cancer, Complications of Hemolysis and Transfusion Therapy, Systems Biology of Tumor-Immune-Stromal Interactions in Metastatic Progression
OpenAlex ID: W4417199203